» Articles » PMID: 26309800

Improved Human Pluripotent Stem Cell Attachment and Spreading on Xeno-Free Laminin-521-Coated Microcarriers Results in Efficient Growth in Agitated Cultures

Overview
Publisher Mary Ann Liebert
Specialty Biology
Date 2015 Aug 27
PMID 26309800
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Human pluripotent stem cells (hPSC) are self-renewing cells having the potential of differentiation into the three lineages of somatic cells and thus can be medically used in diverse cellular therapies. One of the requirements for achieving these clinical applications is development of completely defined xeno-free systems for large-scale cell expansion and differentiation. Previously, we demonstrated that microcarriers (MCs) coated with mouse laminin-111 (LN111) and positively charged poly-l-lysine (PLL) critically enable the formation and evolution of cells/MC aggregates with high cell yields obtained under agitated conditions. In this article, we further improved the MC system into a defined xeno-free MC one in which the MCs are coated with recombinant human laminin-521 (LN521) alone without additional positive charge. The high binding affinity of the LN521 to cell integrins enables efficient initial HES-3 cell attachment (87%) and spreading (85%), which leads to generation of cells/MC aggregates (400 μm in size) and high cell yields (2.4-3.5×10(6) cells/mL) within 7 days in agitated plate and scalable spinner cultures. The universality of the system was demonstrated by propagation of an induced pluripotent cells line in this defined MC system. Long-term pluripotent (>90% expression Tra-1-60) cell expansion and maintenance of normal karyotype was demonstrated after 10 cell passages. Moreover, tri-lineage differentiation as well as directed differentiation into cardiomyocytes was achieved. The new LN521-based MC system offers a defined, xeno-free, GMP-compatible, and scalable bioprocessing platform for the production of hPSC with the quantity and quality compliant for clinical applications. Use of LN521 on MCs enabled a 34% savings in matrix and media costs over monolayer cultures to produce 10(8) cells.

Citing Articles

Suspension culture on microcarriers and as aggregates enables expansion and differentiation of pluripotent stem cells (PSCs).

Vallabhaneni H, Shah T, Shah P, Hursh D Cytotherapy. 2023; 25(9):993-1005.

PMID: 37256241 PMC: 11447601. DOI: 10.1016/j.jcyt.2023.05.002.


An allied reprogramming, selection, expansion and differentiation platform for creating hiPSC on microcarriers.

Lam A, Ho V, Vassilev S, Reuveny S, Oh S Cell Prolif. 2022; 55(8):e13256.

PMID: 36574589 PMC: 9357361. DOI: 10.1111/cpr.13256.


Manufacturing clinical-grade human induced pluripotent stem cell-derived beta cells for diabetes treatment.

Tan L, Chen J, Lim L, Teo A Cell Prolif. 2022; 55(8):e13232.

PMID: 35474596 PMC: 9357357. DOI: 10.1111/cpr.13232.


Suspension Culture of Human Induced Pluripotent Stem Cells in Single-Use Vertical-Wheel™ Bioreactors Using Aggregate and Microcarrier Culture Systems.

E S Nogueira D, Rodrigues C, Hashimura Y, Jung S, Lee B, Cabral J Methods Mol Biol. 2020; 2286:167-178.

PMID: 33381855 DOI: 10.1007/7651_2020_287.


Selection of human induced pluripotent stem cells lines optimization of cardiomyocytes differentiation in an integrated suspension microcarrier bioreactor.

Laco F, Lam A, Woo T, Tong G, Ho V, Soong P Stem Cell Res Ther. 2020; 11(1):118.

PMID: 32183888 PMC: 7076930. DOI: 10.1186/s13287-020-01618-6.


References
1.
Yurchenco P . Basement membranes: cell scaffoldings and signaling platforms. Cold Spring Harb Perspect Biol. 2011; 3(2). PMC: 3039528. DOI: 10.1101/cshperspect.a004911. View

2.
Chen X, Chen A, Woo T, Choo A, Reuveny S, Oh S . Investigations into the metabolism of two-dimensional colony and suspended microcarrier cultures of human embryonic stem cells in serum-free media. Stem Cells Dev. 2010; 19(11):1781-92. DOI: 10.1089/scd.2010.0077. View

3.
Chen A, Ting S, Seow J, Reuveny S, Oh S . Considerations in designing systems for large scale production of human cardiomyocytes from pluripotent stem cells. Stem Cell Res Ther. 2014; 5(1):12. PMC: 4055057. DOI: 10.1186/scrt401. View

4.
Hussain S, Carafoli F, Hohenester E . Determinants of laminin polymerization revealed by the structure of the α5 chain amino-terminal region. EMBO Rep. 2011; 12(3):276-82. PMC: 3059903. DOI: 10.1038/embor.2011.3. View

5.
Carafoli F, Hussain S, Hohenester E . Crystal structures of the network-forming short-arm tips of the laminin β1 and γ1 chains. PLoS One. 2012; 7(7):e42473. PMC: 3409155. DOI: 10.1371/journal.pone.0042473. View